Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

J P Ioannidis, P S Rosenberg, J J Goedert, L J Ashton, T L Benfield, S P Buchbinder, R A Coutinho, J Eugen-Olsen, T Gallart, T L Katzenstein, L G Kostrikis, H Kuipers, L G Louie, S A Mallal, J B Margolick, O P Martinez, L Meyer, N L Michael, E Operskalski, G PantaleoG P Rizzardi, H Schuitemaker, H W Sheppard, G J Stewart, I D Theodorou, H Ullum, E Vicenzi, D Vlahov, D Wilkinson, C Workman, J F Zagury, T R O'Brien, International Meta-Analysis of HIV Host Genetics

Research output: Contribution to journalJournal articleResearchpeer-review

285 Citations (Scopus)

Abstract

BACKGROUND: Studies relating certain chemokine and chemokine receptor gene alleles with the outcome of HIV-1 infection have yielded inconsistent results.

OBJECTIVE: To examine postulated associations of genetic alleles with HIV-1 disease progression.

DESIGN: Meta-analysis of individual-patient data.

SETTING: 19 prospective cohort studies and case-control studies from the United States, Europe, and Australia.

PATIENTS: Patients with HIV-1 infection who were of European or African descent.

MEASUREMENTS: Time to AIDS, death, and death after AIDS and HIV-1 RNA level at study entry or soon after seroconversion. Data were combined with fixed-effects and random-effects models.

RESULTS: Both the CCR5-Delta32 and CCR2-64I alleles were associated with a decreased risk for progression to AIDS (relative hazard among seroconverters, 0.74 and 0.76, respectively; P = 0.01 for both), a decreased risk for death (relative hazard among seroconverters, 0.64 and 0.74; P < 0.05 for both), and lower HIV-1 RNA levels after seroconversion (difference, -0.18 log(10) copies/mL and -0.14 log(10) copies/mL; P < 0.05 for both). Having the CCR5-Delta32 or CCR2-64I allele had no clear protective effect on the risk for death after development of AIDS. The results were consistent between seroconverters and seroprevalent patients. In contrast, SDF-1 3'A homozygotes showed no decreased risk for AIDS (relative hazard for seroconverters and seroprevalent patients, 0.99 and 1.03, respectively), death (relative hazard, 0.97 and 1.00), or death after development of AIDS (relative hazard, 0.81 and 0.97; P > 0.5 for all).

CONCLUSIONS: The CCR5-Delta32 and CCR2-64I alleles had a strong protective effect on progression of HIV-1 infection, but SDF-1 3'A homozygosity carried no such protection.

Original languageEnglish
JournalAnnals of Internal Medicine
Volume135
Issue number9
Pages (from-to)782-95
Number of pages14
ISSN0003-4819
Publication statusPublished - 6 Nov 2001

Keywords

  • Acquired Immunodeficiency Syndrome
  • Alleles
  • Chemokine CXCL12
  • Chemokines, CXC
  • Disease Progression
  • HIV Infections
  • HIV-1
  • Heterozygote
  • Humans
  • Proportional Hazards Models
  • RNA
  • Receptors, CCR2
  • Receptors, CCR5
  • Receptors, Chemokine
  • Regression Analysis
  • Journal Article
  • Meta-Analysis

Cite this